blood cancer Archive — Page 2 of 6
-
April 12, 2023
Research identifies new target that may prevent blood cancer
An international coalition of biomedical researchers co-led by Vanderbilt's Alexander Bick, MD, PhD, has determined a new way to measure the growth rate of precancerous clones of blood stem cells that one day could help doctors lower their patients’ risk of blood cancer. -
March 30, 2023
VUMC researcher selected for Global Scholars Program
Vanderbilt researcher P. Brent Ferrell, MD, is leading one of five projects selected by the 2022 Novartis Institutes for BioMedical Research Global Scholars Program. -
February 2, 2023
Researchers clarify role of blood cell mutations in disease
Vanderbilt researchers have developed a new method to analyze mutations in blood stem cells that can trigger explosive, clonal expansions of abnormal cells. -
January 12, 2023
Chan Zuckerberg Initiative grant supports single-cell study of rare inherited disease
A multidisciplinary team led by Vanderbilt University Medical Center investigator Alexander Bick, MD, PhD, has been awarded a $2 million, four-year grant to study inflammation at the single-cell level in the rare disease RUNX1-FPD. -
November 7, 2022
Journal Watch
-
August 29, 2022
Blood cancer progression
Vanderbilt researchers used single-cell technologies to explore the accumulation of mutations during blood cancer progression, which could help identify strategies for preventing leukemia before it occurs. -
June 24, 2022
Schwartz receives V Foundation for Cancer Research award
The V Foundation for Cancer Research has awarded a $200,000 grant to Jason Schwartz, MD, PhD, assistant professor in the Division of Pediatric Hematology and Oncology, to support his studies of childhood myelodysplastic syndromes (MDS), bone marrow disorders that can lead to cancer.